Animal&Cell Models
B-NDG series immunodeficient mice
Product number
General naming
Application area
110601
Reduce PBMC reconstitution GVHD response and prolong experimental window
110603
Evaluation of pharmacodynamic and toxicity of CD47, SIRPA targeted drugs
112869
This product results in a high level of immune system reconstitution after the transplantation of hematopoietic stem cells, especially for DC cells.
112480
Irradiation is not required to avoid damage to mice caused by irradiation
112479
Promote differentiation of human myeloid cells；Irradiation is not required to avoid damage to mice caused by irradiation
112865
To verify the efficacy of HLA-A2.1 restricted vaccines；Promote the development of human CD8+ T cells
112451
To verify the efficacy of HLA-A11.1 restricted vaccines and antibody-based therapies；Promote the development of human CD8+ T cells
112560
To verify the efficacy of HLA-A24.2 restricted vaccines and antibody-based therapies；Promote the development of human CD8+ T cells
112450
To verify the efficacy of HLA-A3.1 restricted vaccines and antibody-based therapies；Promote the development of human CD8+ T cells
112256
No MHC class I molecule expression; Reduce GVHD and prolong the experimental window period; Improve the accuracy of efficacy verification
111982
Used for pharmacological or pharmacokinetic studies of drugs that utilize albumin to extend their half-life
112653
Promote differentiation of human NK cells；No mouse Fc receptor function
112449
To verify the efficacy of HLA-A2.1 restricted vaccines and antibody-based therapies；Promote the development of human CD8+ T cells
112470
Human immune system reconstitution, mainly T cells and B cells；reconstitutionl Human-derived cell or tissue engraftmentl Tumor research；Human disease model studyl Efficacy and toxicity verification for
112469
Human T cell reconstitution；Human-derived cell or tissue engraftment；Tumor researchl Human disease model study；Efficacy and toxicity verification for human targeted drugs
110593
Promote differentiation of human myeloid cells；For mating with other humanized mice that promote myeloid cell differentiation to obtain multi-humanized mice
110595
No MHC class II molecule expression; Reduce GVHD and prolong the experimental window period；Improve the accuracy of efficacy verification
111882
Promote differentiation of human myeloid cells；Irradiation is not required to avoid damage to mice caused by irradiatio
111895
No MHC class I/II molecule expression；Reduce GVHD and prolong the experimental window period；Improve the accuracy of efficacy verification
Technical support
Quality Assurance
+86-10-56967680
info@bbctg.com.cn
Copyright © 2024 BioMice. All Rights Reserved
Powered by Fractal-technology